US Patent Issued to Janssen Pharmaceutica on Dec. 2 for "Bicyclic HPK1 inhibitors" (French, Belgian, American, Swiss Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,264, issued on Dec. 2, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium).

"Bicyclic HPK1 inhibitors" was invented by Laurence Anne Mevellec (Louviers, France), Jorge Eduardo Vialard (Zurich), Sophie Coupa (Belbeuf, France), Christophe Denis Pascal Adelinet (Iville, France), Berthold Wroblowski (Vosselaar, Belgium) and James Patrick Edwards (Ambler, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as HPK1 inhibitors, useful for treating diseases such as cancer."

The pa...